Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia

Acute myeloid leukemia (AML) is characterized by the accumulation of malignant blasts with impaired differentiation programs caused by recurrent mutations, such as the isocitrate dehydrogenase (IDH) mutations found in 15% of AML patients. These mutations result in the production of the oncometabolit...

Descripción completa

Detalles Bibliográficos
Autores principales: Boutzen, Héléna, Saland, Estelle, Larrue, Clément, de Toni, Fabienne, Gales, Lara, Castelli, Florence A., Cathebas, Mathilde, Zaghdoudi, Sonia, Stuani, Lucille, Kaoma, Tony, Riscal, Romain, Yang, Guangli, Hirsch, Pierre, David, Marion, De Mas-Mansat, Véronique, Delabesse, Eric, Vallar, Laurent, Delhommeau, François, Jouanin, Isabelle, Ouerfelli, Ouathek, Le Cam, Laurent, Linares, Laetitia K., Junot, Christophe, Portais, Jean-Charles, Vergez, François, Récher, Christian, Sarry, Jean-Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821643/
https://www.ncbi.nlm.nih.gov/pubmed/26951332
http://dx.doi.org/10.1084/jem.20150736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821643/
https://www.ncbi.nlm.nih.gov/pubmed/26951332
http://dx.doi.org/10.1084/jem.20150736

Ejemplares similares